FI56679C - 3-amino-2,4,6-trijodfenyl- eller -bensoylalkansyror som anvaendes som roentgenkontrastmedel och dessa foereningars farmaceutiskt godtagbara salter - Google Patents

3-amino-2,4,6-trijodfenyl- eller -bensoylalkansyror som anvaendes som roentgenkontrastmedel och dessa foereningars farmaceutiskt godtagbara salter Download PDF

Info

Publication number
FI56679C
FI56679C FI2021/73A FI202173A FI56679C FI 56679 C FI56679 C FI 56679C FI 2021/73 A FI2021/73 A FI 2021/73A FI 202173 A FI202173 A FI 202173A FI 56679 C FI56679 C FI 56679C
Authority
FI
Finland
Prior art keywords
amino
acid
pyrrolidinylidene
group
triiodobenzoyl
Prior art date
Application number
FI2021/73A
Other languages
English (en)
Finnish (fi)
Other versions
FI56679B (fi
Inventor
Irmgard Dr Lindner
Ernst Schwarzinger
Josef Krieger
Werner Dr Oberndorf
Original Assignee
Chemie Linz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19722235915 external-priority patent/DE2235915C3/de
Application filed by Chemie Linz Ag filed Critical Chemie Linz Ag
Priority claimed from FR7326276A external-priority patent/FR2193620A1/fr
Application granted granted Critical
Publication of FI56679B publication Critical patent/FI56679B/fi
Publication of FI56679C publication Critical patent/FI56679C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/12—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0452—Solutions, e.g. for injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0495—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound intended for oral administration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
FI2021/73A 1972-07-21 1973-06-21 3-amino-2,4,6-trijodfenyl- eller -bensoylalkansyror som anvaendes som roentgenkontrastmedel och dessa foereningars farmaceutiskt godtagbara salter FI56679C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE2235915 1972-07-21
DE19722235915 DE2235915C3 (de) 1972-07-21 N-eckige Klammer auf 3-Pyrrolidinyliden-(2'-amino-2,4,6-trijodbenzoyl eckige Klammer zu - aminosäuren, deren Herstellung und Verwendung
FR7326276A FR2193620A1 (en) 1972-07-21 1973-07-18 3-Amidino 2,4,6-tri-iodobenzene derivs
FR7326276 1973-07-18

Publications (2)

Publication Number Publication Date
FI56679B FI56679B (fi) 1979-11-30
FI56679C true FI56679C (fi) 1980-03-10

Family

ID=25763602

Family Applications (1)

Application Number Title Priority Date Filing Date
FI2021/73A FI56679C (fi) 1972-07-21 1973-06-21 3-amino-2,4,6-trijodfenyl- eller -bensoylalkansyror som anvaendes som roentgenkontrastmedel och dessa foereningars farmaceutiskt godtagbara salter

Country Status (15)

Country Link
US (1) US3925412A (fr)
JP (1) JPS5331866B2 (fr)
BE (1) BE806666A (fr)
CA (1) CA991191A (fr)
CH (1) CH592451A5 (fr)
CS (1) CS184331B2 (fr)
DD (1) DD107909A1 (fr)
DK (1) DK138580C (fr)
FI (1) FI56679C (fr)
GB (1) GB1393231A (fr)
IE (1) IE37903B1 (fr)
LU (1) LU67968A1 (fr)
NL (1) NL7310135A (fr)
SE (1) SE393608B (fr)
ZA (1) ZA734789B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6133688U (ja) * 1984-07-28 1986-02-28 建設省九州地方建設局長 管内内容物の取り出し装置
US5614638A (en) * 1989-11-29 1997-03-25 Bracco International B.V. Nonionic radiographic contrast agents
US5869024A (en) * 1989-11-29 1999-02-09 Bracco International B.V. Methods and compositions for using non-ionic contrast agents to reduce the risk of clot formation in diagnostic procedures
US5527926A (en) * 1990-11-26 1996-06-18 Bracco International B.V. Methods and compositions for using non-ionic contrast agents to reduce the risk of clot formation in diagnostic procedures
CA2068089C (fr) * 1991-05-31 2003-09-16 Ramachandran S. Ranganathan Methode et compositions pour l'utilisation d'agents de contraste non ioniques reduisant le risque de formation de caillots dans les methodes diagnostiques
US5278311A (en) * 1992-06-05 1994-01-11 E. R. Squibb & Sons, Inc. Nonionic radiographic contrast agents
US20050008699A1 (en) * 2003-07-11 2005-01-13 Fred Wehling Effervescent glucosamine composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3609147A (en) * 1969-03-19 1971-09-28 Sterling Drug Inc 3-heterocyclic imido-5-substituted-2,4,6-triiodo benzoic acids and derivatives thereof
DE1956844C3 (de) * 1969-11-08 1979-02-22 Schering Ag, 1000 Berlin Und 4619 Bergkamen ß-(2,4,6-Trijod-3-amidinophenyl)propionsäuren, deren Herstellung und mindestens eine dieser Verbindungen enthaltende Röntgenkontrastmittel
US3666760A (en) * 1970-04-02 1972-05-30 Sterling Drug Inc Iodinated 3-aminobenzamides

Also Published As

Publication number Publication date
IE37903B1 (en) 1977-11-09
LU67968A1 (fr) 1973-09-11
SE393608B (sv) 1977-05-16
DK138580B (da) 1978-10-02
CA991191A (en) 1976-06-15
NL7310135A (fr) 1974-01-23
ZA734789B (en) 1974-06-26
DK138580C (da) 1979-03-05
DE2235915B2 (de) 1976-04-22
GB1393231A (en) 1975-05-07
FI56679B (fi) 1979-11-30
DD107909A1 (fr) 1974-08-20
US3925412A (en) 1975-12-09
CS184331B2 (en) 1978-08-31
IE37903L (en) 1974-01-21
DE2235915A1 (de) 1974-02-07
JPS4955658A (fr) 1974-05-30
JPS5331866B2 (fr) 1978-09-05
CH592451A5 (fr) 1977-10-31
BE806666A (fr) 1974-04-29

Similar Documents

Publication Publication Date Title
ES2540810T3 (es) Proceso para preparar compuestos azabicíclicos
JP2001527058A (ja) ノイラミニダーゼ阻害剤として有用な置換シクロペンタン及びシクロペンテン化合物
EP3509582A1 (fr) Forme de solvate de carbamate de (r) -2-amino-3-phénylpropyle
BRPI0514351A2 (pt) hidratos e polimorfos de 4-[[(7r)-8-ciclopentil-7-etil-5,6,7,8-tetrahidro-5-metil-4- 6-oxo -2-pteridinil]amino]-3-metóxi-n-(1-metil-4-piperidinil)-b enzamida, processos para sua preparação e seu uso como medicamento
RU2125571C1 (ru) СОЛЬ 7-([1α,5α,6α]-6-АМИНО-3-АЗАБИЦИКЛО [3.1.0] ГЕКС-3-ИЛ)-6-ФТОР-1-(2,4-ДИФТОРФЕНИЛ)-1,4- ДИГИДРО-4-ОКСО-1,8-НАФТИРИДИН-3-КАРБОНОВОЙ И МЕТАНСУЛЬФОНОВОЙ КИСЛОТ И СПОСОБ ЕЕ ПОЛУЧЕНИЯ
WO2011033296A1 (fr) Promédicaments de guanfacine
CZ292423B6 (cs) Krystalický, bezvodý mykofenolát mofetilu a intravenózní prostředek, ve kterém je obsažen
KR960003327B1 (ko) 디클로페낙과 환상 유기염기와의 염 및 이를 함유한 약학적 조성물
FI56679C (fi) 3-amino-2,4,6-trijodfenyl- eller -bensoylalkansyror som anvaendes som roentgenkontrastmedel och dessa foereningars farmaceutiskt godtagbara salter
WO2017156403A1 (fr) Formes salines cristallines
JPH09110830A (ja) Ｎ−メチル−ｎ−［（１ｓ）−１−フェニル−２−｛（３ｓ）−３−ヒドロキシピロリジン−１−イル｝エチル］−２，２−ジフェニルアセトアミド
FI61872C (fi) Derivat av trijoderade aminobensenkarboxylsyror anvaenda som roentgenkontrastmedel
JPS6020394B2 (ja) 抗生物質の製造方法
US7132541B2 (en) Crystalline fluoroquinolone arginine salt form
JP3190679B2 (ja) 複素環式化学
CS200231B2 (en) Process for preparing n-substituted lactames
JPS6319506B2 (fr)
CS209855B2 (en) Method of making the new aminoacids derivatives
ES2876004T3 (es) Formulaciones farmacéuticas que contienen derivados de 3-(4-cinamil-L-piperazinil) amino de 3-formilrifamicina S
RU2168493C2 (ru) Производные l-аргинина, способ их получения, фармацевтическая композиция, обладающая ингибирующей no-синтазу активностью
ES2207325T3 (es) ((aminoiminomethil) amino) alcanocarboxamidas y sus aplicaciones terapeuticas.
JP2002524538A (ja) 放射線造影剤
MXPA01012325A (es) Formas polimorfas de un citrato cristalino de azobiciclo(2.2.2)octan-3-amina y sus composiciones farmaceuticas.
FI66353C (fi) Analogifoerfarande foer framstaellning av terapeutiskt anvaendbara 1-amino-(laegre-alkyl)-3,4-difenyl-1h-pyrazoler
US4025550A (en) Derivatives of triiodo-aminobenzenecarboxylic acids and the preparation thereof